BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 26706279)

  • 1. NLRP3 inflammasome activation during myocardial ischemia reperfusion is cardioprotective.
    Sandanger Ø; Gao E; Ranheim T; Bliksøen M; Kaasbøll OJ; Alfsnes K; Nymo SH; Rashidi A; Ohm IK; Attramadal H; Aukrust P; Vinge LE; Yndestad A
    Biochem Biophys Res Commun; 2016 Jan; 469(4):1012-20. PubMed ID: 26706279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The NLRP3 inflammasome is up-regulated in cardiac fibroblasts and mediates myocardial ischaemia-reperfusion injury.
    Sandanger Ø; Ranheim T; Vinge LE; Bliksøen M; Alfsnes K; Finsen AV; Dahl CP; Askevold ET; Florholmen G; Christensen G; Fitzgerald KA; Lien E; Valen G; Espevik T; Aukrust P; Yndestad A
    Cardiovasc Res; 2013 Jul; 99(1):164-74. PubMed ID: 23580606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cathelicidin aggravates myocardial ischemia/reperfusion injury via activating TLR4 signaling and P2X
    Wu Y; Zhang Y; Zhang J; Zhai T; Hu J; Luo H; Zhou H; Zhang Q; Zhou Z; Liu F
    J Mol Cell Cardiol; 2020 Feb; 139():75-86. PubMed ID: 31982429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TXNIP mediates NLRP3 inflammasome activation in cardiac microvascular endothelial cells as a novel mechanism in myocardial ischemia/reperfusion injury.
    Liu Y; Lian K; Zhang L; Wang R; Yi F; Gao C; Xin C; Zhu D; Li Y; Yan W; Xiong L; Gao E; Wang H; Tao L
    Basic Res Cardiol; 2014; 109(5):415. PubMed ID: 25015733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NLRP3 Inflammasome in Cardioprotective Signaling.
    Zuurbier CJ
    J Cardiovasc Pharmacol; 2019 Oct; 74(4):271-275. PubMed ID: 31356546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Re. "NLRP3 inflammasome activation during myocardial ischemia reperfusion is cardioprotective".
    Toldo S; Marchetti C; Abbate A
    Biochem Biophys Res Commun; 2016 Feb; 470(4):811-2. PubMed ID: 26797280
    [No Abstract]   [Full Text] [Related]  

  • 7. Naoxintong attenuates Ischaemia/reperfusion Injury through inhibiting NLRP3 inflammasome activation.
    Wang Y; Yan X; Mi S; Li Z; Wang Y; Zhu H; Sun X; Zhao B; Zhao C; Zou Y; Hu K; Ding X; Sun A; Ge J
    J Cell Mol Med; 2017 Jan; 21(1):4-12. PubMed ID: 27785882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NLRP3 regulates neutrophil functions and contributes to hepatic ischemia-reperfusion injury independently of inflammasomes.
    Inoue Y; Shirasuna K; Kimura H; Usui F; Kawashima A; Karasawa T; Tago K; Dezaki K; Nishimura S; Sagara J; Noda T; Iwakura Y; Tsutsui H; Taniguchi S; Yanagisawa K; Yada T; Yasuda Y; Takahashi M
    J Immunol; 2014 May; 192(9):4342-51. PubMed ID: 24696236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The NLRP3/ASC inflammasome promotes T-cell-dependent immune complex glomerulonephritis by canonical and noncanonical mechanisms.
    Andersen K; Eltrich N; Lichtnekert J; Anders HJ; Vielhauer V
    Kidney Int; 2014 Nov; 86(5):965-78. PubMed ID: 24805106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deletion of the innate immune NLRP3 receptor abolishes cardiac ischemic preconditioning and is associated with decreased Il-6/STAT3 signaling.
    Zuurbier CJ; Jong WM; Eerbeek O; Koeman A; Pulskens WP; Butter LM; Leemans JC; Hollmann MW
    PLoS One; 2012; 7(7):e40643. PubMed ID: 22848390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardioprotective activity of ethyl acetate extract of Cinnamomi Ramulus against myocardial ischemia/reperfusion injury in rats via inhibiting NLRP3 inflammasome activation and pyroptosis.
    Peng L; Lei Z; Rao Z; Yang R; Zheng L; Fan Y; Luan F; Zeng N
    Phytomedicine; 2021 Dec; 93():153798. PubMed ID: 34673348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of the NLRP3 inflammasome limits the inflammatory injury following myocardial ischemia-reperfusion in the mouse.
    Toldo S; Marchetti C; Mauro AG; Chojnacki J; Mezzaroma E; Carbone S; Zhang S; Van Tassell B; Salloum FN; Abbate A
    Int J Cardiol; 2016 Apr; 209():215-20. PubMed ID: 26896627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resveratrol pretreatment protects rat hearts from ischemia/reperfusion injury partly via a NALP3 inflammasome pathway.
    Dong W; Yang R; Yang J; Yang J; Ding J; Wu H; Zhang J
    Int J Clin Exp Pathol; 2015; 8(8):8731-41. PubMed ID: 26464617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reperfusion therapy with recombinant human relaxin-2 (Serelaxin) attenuates myocardial infarct size and NLRP3 inflammasome following ischemia/reperfusion injury via eNOS-dependent mechanism.
    Valle Raleigh J; Mauro AG; Devarakonda T; Marchetti C; He J; Kim E; Filippone S; Das A; Toldo S; Abbate A; Salloum FN
    Cardiovasc Res; 2017 May; 113(6):609-619. PubMed ID: 28073832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cinnamic acid preserves against myocardial ischemia/reperfusion injury via suppression of NLRP3/Caspase-1/GSDMD signaling pathway.
    Luan F; Rao Z; Peng L; Lei Z; Zeng J; Peng X; Yang R; Liu R; Zeng N
    Phytomedicine; 2022 Jun; 100():154047. PubMed ID: 35320770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NLRP3 and ASC differentially affect the lung transcriptome during pneumococcal pneumonia.
    van Lieshout MH; Scicluna BP; Florquin S; van der Poll T
    Am J Respir Cell Mol Biol; 2014 Apr; 50(4):699-712. PubMed ID: 24164497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Puerarin protects against myocardial ischemia/reperfusion injury by inhibiting inflammation and the NLRP3 inflammasome: The role of the SIRT1/NF-κB pathway.
    Wang ZK; Chen RR; Li JH; Chen JY; Li W; Niu XL; Wang FF; Wang J; Yang JX
    Int Immunopharmacol; 2020 Dec; 89(Pt B):107086. PubMed ID: 33068868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Splenic monocytes mediate inflammatory response and exacerbate myocardial ischemia/reperfusion injury in a mitochondrial cell-free DNA-TLR9-NLRP3-dependent fashion.
    Xie D; Guo H; Li M; Jia L; Zhang H; Liang D; Wu N; Yang Z; Tian Y
    Basic Res Cardiol; 2023 Oct; 118(1):44. PubMed ID: 37814087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological Inhibition of NLRP3 Inflammasome Attenuates Myocardial Ischemia/Reperfusion Injury by Activation of RISK and Mitochondrial Pathways.
    Mastrocola R; Penna C; Tullio F; Femminò S; Nigro D; Chiazza F; Serpe L; Collotta D; Alloatti G; Cocco M; Bertinaria M; Pagliaro P; Aragno M; Collino M
    Oxid Med Cell Longev; 2016; 2016():5271251. PubMed ID: 28053692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Scutellarin protects against myocardial ischemia-reperfusion injury by suppressing NLRP3 inflammasome activation.
    Xu LJ; Chen RC; Ma XY; Zhu Y; Sun GB; Sun XB
    Phytomedicine; 2020 Mar; 68():153169. PubMed ID: 31999976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.